Latest News - Baxter
Top Corporates Hub
Baxter
Has Baxter International (BAX) Overreacted After Recent 10.9% Weekly Share Price Jump
24.05.2026 06:11
Wondering whether Baxter International at around US$19.18 is a bargain or a value trap? This article walks through what the current price might actually imply. The stock has moved sharply in the short term, with a 10.9% gain over the past week and 5.6% over the past month, despite being down 1.6% year to date and declining 35.5% over the past year and 50.2% over three years. These moves sit against an ongoing evergreen interest in Baxter International as a large healthcare equipment company...
1 Stock Under $50 Worth Investigating and 2 Facing Challenges
23.05.2026 14:44
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to volatility as many lack the scale advantages of their larger peers.
Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)
22.05.2026 06:12
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Baxter (NYSE:BAX) and its peers.
Medical Adhesives Research and Forecast Report 2026-2035: $23+ Bn Market is Fiercely Competitive, Featuring Giants Like 3M Company, Avery Dennison, Baxter, Dow Chemical, H.B. Fuller, and Henkel
18.05.2026 14:31
The medical adhesives market is poised for growth driven by the rise in minimally invasive surgeries, demand for advanced wound care, and wearable tech. Key opportunities lie in developing smart, biocompatible, and eco-friendly options, especially in Asia, with a focus on internal medical applications and water-based technologies.Dublin, May 18, 2026 (GLOBE NEWSWIRE) -- The "Medical Adhesives Market, Till 2035: Distribution by Type of Resin, Type of Technology, Areas of Application, Type of Ente
First Pacific Advisors' Strategic Moves: Baxter International Inc. Takes Center Stage
14.05.2026 12:00
Exploring the Latest 13F Filing and Investment Strategies
Baxter International Stock Outlook: Is Wall Street Bullish or Bearish?
05.05.2026 03:37
As Baxter International has notably underperformed the broader market over the past year, Wall Street analysts maintain a cautious outlook about the stock’s prospects.
Barclays Maintains Overweight on Baxter International, Raises Price Target to $27
04.05.2026 10:23
Barclays analyst Matt Miksic maintains Baxter International (NYSE:BAX) with a Overweight and raises the price target from $25 to $27.
Assessing Baxter International (BAX) Valuation After Earnings Beat And Reaffirmed Outlook
03.05.2026 12:04
Baxter International (BAX) has drawn fresh attention after reporting first quarter 2026 results that topped Wall Street expectations on revenue and adjusted earnings, while reaffirming full year guidance despite a GAAP net loss. See our latest analysis for Baxter International. Despite the positive earnings surprise and reaffirmed outlook, Baxter’s 1 day share price return of a 2.1% decline and 7 day share price return of a 5.23% decline sit against a 1 year total shareholder return of a...
Baxter Profit Plunges 35% As Tariffs, Costs Bite
01.05.2026 07:54
Baxter tops earnings, but profit plunges 35% as tariffs and manufacturing costs rise; outlook for 2026 remains intact.
Baxter (BAX) Q1 2026 Earnings Call Transcript
01.05.2026 01:36
Joining me today are Andrew Hider, President and Chief Executive Officer; and Anita Zielinski, Interim Chief Financial Officer, Chief Accounting Officer and Controller. During the call, we will be making forward-looking statements, including comments regarding our reiterated financial outlook for the full year 2026 and the anticipated drivers of the second quarter and second half 2026 performance.
Earnings Preview: QuidelOrtho (QDEL) Q1 Earnings Expected to Decline
28.04.2026 14:00
QuidelOrtho (QDEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Baxter International (BAX) to Report a Decline in Earnings: What to Look Out for
23.04.2026 14:00
Baxter (BAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is It Time To Reassess Baxter International (BAX) After A 35.9% One Year Share Price Slide
16.04.2026 11:06
For investors weighing whether Baxter International's current share price offers value or simply more volatility after a tough few years, this breakdown focuses squarely on what the numbers indicate about the stock. The share price recently closed at US$17.60, with returns of 2.1% over 7 days and 3.0% over 30 days. Year to date the stock shows a 9.7% decline and the 1-year return is 35.9% in the red. Recent coverage has highlighted Baxter International as a long-established medical products...
Baxter Showcases Recent Innovations at AORN Global Surgical Conference and Expo 2026
14.04.2026 09:47
Baxter International Inc. , a global medtech leader, is highlighting recent additions to its Global Surgical Solutions and Patient Support Systems portfolios, as well as its broad Advanced Surgery...
How Investors May Respond To Baxter International (BAX) Expanding Into Automated IV Line Labeling Systems
04.04.2026 05:07
Baxter International has launched the IV Verify Line Labeling System in the U.S. after debuting it at the 2026 American Organization for Nursing Leadership Conference, offering an automated way to print standardized, color‑coded IV tubing labels that integrate barcodes, timing details, and patented ink‑free technology. The exclusive distribution agreement with Vigilant Software positions Baxter more firmly in medication safety automation, targeting persistent IV line labeling errors that can...
Leading Brands to Share ESG and Climate Strategies at Sustainability LIVE: The US Summit
30.03.2026 17:15
London, 30 March 2026 – BizClik and Sustainability Magazine has announced a distinguished lineup of Chief Sustainability Officers and sustainability leaders for Sustainability LIVE: The US Summit, taking place at Navy Pier, Chicago, on 21-22 April. The two-day event will bring together senior executives from some of the world's most recognised brands to address the evolving role of sustainability leadership in driving business transformation and measurable impact. Among the confirmed speakers ar
Baxter Introduces the IV Verify Line Labeling System, an Automated Solution to Improve IV Labeling in Healthcare Settings
30.03.2026 12:30
DEERFIELD, Ill., March 30, 2026--Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and platforms, today debuted the IV Verify Line Labeling System, an automated solution, at the 2026 American Organization for Nursing Leadership Conference. The IV Verify system is designed to streamline nursing workflows, save clinician time and support safer medication administration at the bedside. Baxter’s launch of the product is the result of a strategic and exclusive distribut
Clinical Nutrition for Cancer Care: 2026-2030 Market Analysis Featuring Profiles of Leading Players - Abbott Nutrition, Baxter International, B Braun Melsungen, Nestle Health Science, Danone Nutricia and More
27.03.2026 14:39
Clinical Nutrition for Cancer Care Market Clinical Nutrition for Cancer Care Market Dublin, March 27, 2026 (GLOBE NEWSWIRE) -- The "Clinical Nutrition for Cancer Care Market Report 2026" has been added to ResearchAndMarkets.com's offering. The clinical nutrition for cancer care market has experienced substantial growth, with the market size set to increase from $5.16 billion in 2025 to $5.42 billion in 2026, representing a compound annual growth rate (CAGR) of 5.1%. This upward trend is driven b
Bank of America Maintains a Hold Rating on Baxter International (BAX)
27.03.2026 07:24
Baxter International Inc. (NYSE:BAX) is one of the Best Mid Cap Value Stocks to Buy in 2026. On March 17, Travis Steed from Bank of America Securities maintained a Hold rating on Baxter International Inc. (NYSE:BAX) with a price target of $24. The rating comes after the S&P downgraded its outlook on the stock from […]